Agency urges researchers to make more use of yellow card data

BMJ 2007; 335 doi: (Published 01 November 2007) Cite this as: BMJ 2007;335:907
  1. Roger Dobson
  1. Abergavenny

    Researchers are being urged to make more use of yellow card data on reported adverse reactions to drugs in the United Kingdom.

    The call from the Medicines and Healthcare Products Regulatory Agency comes after the publication of the first annual report by its independent scientific advisory committee. The committee reviews the scientific merit of proposals for using data from the card scheme and the general practice research database in research.

    “The potential of the data we hold for public health research is unparalleled, and I am delighted that the launch of this first report shows that this is increasingly recognised by researchers,” said …

    View Full Text

    Sign in

    Log in through your institution